Oragenics Inc. (OGEN) analyst actions
Rating and price-target actions on OGEN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the OGEN overview →
1 measured OGEN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION | Press release | -1.92% | -2.97% |
Keep exploring
More OGEN: earnings → · SEC filings → · OGEN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | 245 | 0.00% | 49% |
| electroCore, Inc. (ECOR) | 245 | 0.00% | 47% |
| Universal Health Services, Inc. (UHS) | 245 | -0.04% | 49% |
| UNUM THERAPEUTICS INC COMMON (UMRX) | 245 | -0.89% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.